Lamotrigine for Absence Seizures
The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pediatric Neurology Briefs Publishers
1999-08-01
|
| Col·lecció: | Pediatric Neurology Briefs |
| Matèries: | |
| Accés en línia: | https://www.pediatricneurologybriefs.com/articles/2034 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|